Mental health parity, and why it hasn't landed

What the law actually says

The Mental Health Parity and Addiction Equity Act, passed in 2008, doesn't require a plan to cover mental health care. It requires that if it does, the limits it puts on that care can't be more restrictive than the limits it puts on medical and surgical care. Same principle, applied to money and to rules.

That's a genuinely important law, and it did real work. The crude disparities, a separate and higher copay for a psychiatrist, a hard cap of twenty visits a year, a separate deductible, largely disappeared. If parity had been only about those, it would be a finished story.

Where the disparity moved

It didn't disappear. It went somewhere harder to photograph.

If you can't charge a different copay, you can still require prior authorization for a psychiatric admission and not for a medical one. You can apply a stricter definition of medical necessity. You can review continued stays more aggressively. You can reimburse so poorly that clinicians leave the panel, and then point at the resulting directory, which is how parity connects directly to ghost networks. Nothing on that list shows up as a number on a benefits summary. All of it shows up in whether a person actually gets care.

Nonquantitative treatment limitations

The regulatory term for that second category is nonquantitative treatment limitations, and the acronym, NQTL, is one worth knowing because it's where the entire fight lives. The Consolidated Appropriations Act of 2021 required plans to produce comparative analyses showing that their NQTLs are applied no more stringently to mental health than to medical care, and to hand those analyses over on request.

That was the moment parity got teeth, at least on paper. It shifted the question from "is the copay the same" to "show your work on why you deny psychiatric admissions at four times the rate."

Where it stands, as of July 2026

In September 2024 the Departments of Labor, Health and Human Services, and the Treasury issued a final rule tightening those comparative analysis requirements. It took effect in late 2024, with provisions phasing in across 2025 and 2026.

Then it stalled. Industry litigation followed, and in 2025 the Departments announced a non-enforcement policy for the portions of the 2024 rule that were new, pending a final decision in that litigation plus an additional period, while they reconsider the rule.

Read that carefully, because it's easy to overstate in both directions. The 2008 statute is still law. The 2013 rules still apply. The comparative analysis obligation created by the 2021 statute still exists. What's paused is enforcement of the newest layer. This is a live, moving situation, which is exactly why this page carries a date.

What it means if you're the clinician

Practically, three things. Denials and prior authorization requirements are the surface where parity is contested, so the appeal you write is not administrative noise, it's the evidence. Patients generally have a right to the plan's medical necessity criteria and, under the comparative analysis requirements, plans can be asked to show their reasoning. Most people never ask, and plans are counting on that.

And the panel economics that drive psychiatrists out of insurance in the first place are a parity question wearing an accounting costume. A plan that reimburses psychiatry so thinly that nobody stays in network has produced a coverage disparity as effective as any copay, and considerably harder to see. That's the honest connection between this page, cash pay versus insurance, and the access problem the whole field keeps circling.